Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Ashley H. Vernon"'
Autor:
Sigrid Bairdain, Mark Cleary, Chueh Lien, Ashley H. Vernon, Bradley C. Linden, David B. Lautz
Publikováno v:
Case Reports in Endocrinology, Vol 2013 (2013)
Obesity is commonplace, and surgical treatment usually includes Roux-en-Y gastric bypasses (RYGBs). RYGBs have the most documented side effects including vitamin deficiencies, rebound weight gain, and symptomatic hypoglycemia; fewer series exist desc
Externí odkaz:
https://doaj.org/article/adcb22f2d482406aaf652d4ef5609cfc
Autor:
John P. Kirwan, Anita P. Courcoulas, David E. Cummings, Allison B. Goldfine, Sangeeta R. Kashyap, Donald C. Simonson, David E. Arterburn, William F. Gourash, Ashley H. Vernon, John M. Jakicic, Mary Elizabeth Patti, Kathy Wolski, Philip R. Schauer
OBJECTIVE The overall aim of the Alliance of Randomized Trials of Medicine versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) consortium is to assess the durability and longer-term effectiveness of metabolic surgery compared with medical/lifesty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91f0757e0aeb7752eaacb4a50d7f86b
https://doi.org/10.2337/figshare.19237437.v1
https://doi.org/10.2337/figshare.19237437.v1
Autor:
Donald C. Simonson, Bo Hu, David E. Arterburn, Philip R. Schauer, Sangeeta R. Kashyap, Anita P. Courcoulas, David E. Cummings, Mary‐Elizabeth Patti, William F. Gourash, Ashley H. Vernon, John M. Jakicic, John P. Kirwan
Publikováno v:
Diabetes Obes Metab
AIMS: Long-term data from randomized clinical trials comparing metabolic (bariatric) surgery vs. a medical/lifestyle intervention for treatment of patients with obesity/overweight and type 2 diabetes (T2D) are lacking. The Alliance of Randomized Tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997085c8ffc015df8defd8d0ebe46500
https://europepmc.org/articles/PMC9177689/
https://europepmc.org/articles/PMC9177689/
Autor:
null Donald C. Simonson, null Bo Hu, null David E. Arterburn, null Philip R. Schauer, null Sangeeta R. Kashyap, null Anita P. Courcoulas, null David E. Cummings, null Mary‐Elizabeth Patti, null William F. Gourash, null Ashley H. Vernon, null John M. Jakicic, null John P. Kirwan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb74a3a6f2d64ddcc9560e313cf04115
https://doi.org/10.1111/dom.14680/v2/response1
https://doi.org/10.1111/dom.14680/v2/response1
Autor:
Hassan Aliakbarian, David A. Harris, Eric G. Sheu, James N. Luo, Snehal N. Chaudhari, Matthew T. Henke, Ashley H. Vernon, Renuka Subramaniam, Ali Tavakkoli, A. Sloan Devlin
Publikováno v:
Nature Chemical Biology. 17:20-29
Bariatric surgery, the most effective treatment for obesity and type 2 diabetes, is associated with increased levels of the incretin hormone glucagon-like peptide-1 (GLP-1) and changes in levels of circulating bile acids. The levels of individual bil
Autor:
Kathleen Foster, Ashley H. Vernon, Donald C. Simonson, Allison B. Goldfine, Florencia Halperin, Mary-Elizabeth Patti
Publikováno v:
Surgery for Obesity and Related Diseases. 15:2052-2059
Few randomized trials have compared surgical versus lifestyle and pharmacologic approaches for type 2 diabetes (T2D) patients with mild to moderate obesity.This study examined resolution of hyperglycemia (A1C6.5% and fasting glucose126 mg/dL) 3 years
Autor:
JOHN P. KIRWAN, ANITA COURCOULAS, DAVID E. CUMMINGS, ALLISON GOLDFINE, SANGEETA KASHYAP, DONALD C. SIMONSON, DAVID ARTERBURN, WILLIAM F. GOURASH, ASHLEY H. VERNON, JOHN M. JAKICIC, MARY-ELIZABETH PATTI, KATHERINE WOLSKI, PHILIP SCHAUER
Publikováno v:
Diabetes. 70
There is limited Level-1 evidence from well-powered randomized controlled trials (RCTs) examining improved glycemic control after metabolic surgery in patients with type 2 diabetes (T2D) and obesity. ARMMS-T2D is a multi-center consortium conducting
Autor:
Xavier Michelet, Róisín M. Loftus, Kingston H. G. Mills, Danielle Duquette, Andrew E. Hogan, Lydia Lynch, Barbara S. Nikolajczyk, Michael B. Brenner, Lydia Dyck, Cliona O'Farrelly, Cathriona Foley, Ashley H. Vernon, David K. Finlay, William Pettee, Raymond P. Donnelly, Kevin Wei, Ali Tavakkoli, Semir Beyaz, Mathilde Raverdeau, Donal O'Shea
Publikováno v:
Nature Immunology
Up to 49% of certain types of cancer are attributed to obesity, and potential mechanisms include overproduction of hormones, adipokines, and insulin. Cytotoxic immune cells, including natural killer (NK) cells and CD8+ T cells, are important in tumor
Autor:
Mukaila A. Raji, Peter Peduzzi, Katy L. B. Araujo, Martie Carnie, Ilene G. Ladd, Erin M Unger, Sitara Abraham, Rebecca V. Galloway, Maya Lichtenstein, Alan B. Stevens, Can Meng, Lisa Weitzman, Glen R. Finney, Alanna Kulchak Rahm, Rafael Samper-Ternent, Ashley H. Vernon, Elena Volpi, David M. Bass, Peter Charpentier, Nancy Wilson, Roxana M. Hirst, David B. Reuben, Jeff D. Williamson, Kristin M. Lenoir, Zaldy S. Tan, Jodi Liu, Erich J. Greene, Aval NaʼRee S. Green, James Dziura, Mia Yang, Thomas M. Gill, Lee A. Jennings, Katherine Currie, Leslie Chang Evertson, Pamela Borek
Publikováno v:
Journal of the American Geriatrics Society, vol 68, iss 11
J Am Geriatr Soc
J Am Geriatr Soc
Author(s): Reuben, David B; Gill, Thomas M; Stevens, Alan; Williamson, Jeff; Volpi, Elena; Lichtenstein, Maya; Jennings, Lee A; Tan, Zaldy; Evertson, Leslie; Bass, David; Weitzman, Lisa; Carnie, Martie; Wilson, Nancy; Araujo, Katy; Charpentier, Peter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45b8478798e3fe5b1a6bc66ce3390a6e
https://escholarship.org/uc/item/2zt2w9n0
https://escholarship.org/uc/item/2zt2w9n0
Autor:
Ashley H. Vernon, Donggi Paik, Scott T. Weiss, David A. Harris, Jun R. Huh, Hassan Aliakbarian, Ayşe Kılıç, Renuka Subramaniam, A. Sloan Devlin, Eric G. Sheu, Arijit A. Adhikari, Snehal N. Chaudhari, Lina Yao, James N. Luo
Publikováno v:
Cell hostmicrobe. 29(3)
Bariatric surgery is the most effective treatment for type 2 diabetes and is associated with changes in gut metabolites. Previous work uncovered a gut-restricted TGR5 agonist with anti-diabetic properties-cholic acid-7-sulfate (CA7S)-that is elevated